Construct: ORF ccsbBroadEn_06489
Construct Description:
- Construct Type:
- ORF
- Other Identifiers:
- ORF015827.1_s300c1, BRDN0000389241
- DNA Barcode:
- None
- Epitope Tag:
- None
- Notes:
- No stop codon in insert
Originally Annotated References:
- Gene:
- KIR3DL1 (3811)
Vector Information:
- Vector Backbone:
- pDONR223
- Pol II Cassette 1:
- n/a
- Pol II Cassette 2:
- n/a
- Selection Marker:
- n/a
- Visible Reporter:
- n/a
- Epitope Tag:
- n/a
Current transcripts matched by this ORF:
Taxon | Gene | Symbol | Description | Transcript | Nuc. Match %[?]A simple nucleotide-based global alignment percentage, calculated as follows: total nt. matches ---------------------------------- aligned length (incl. gaps) |
Prot. Match %[?]A simple amino acid-based global alignment percentage, calculated as follows: total aa. matches ---------------------------------- aligned length (incl. gaps) |
Match Diffs[?]This field may contain sequence annotations in HGVS format. For more information about HGVS annotations, please refer to the HGVS Quick Reference Guide. | |
---|---|---|---|---|---|---|---|---|
1 | human | 3811 | KIR3DL1 | killer cell immunoglobulin ... | NM_013289.2 | 99.6% | 99.3% | (many diffs) |
2 | human | 3811 | KIR3DL1 | killer cell immunoglobulin ... | NM_001322168.1 | 99.3% | 98.6% | (many diffs) |
3 | human | 3812 | KIR3DL2 | killer cell immunoglobulin ... | NM_006737.4 | 90.7% | 83.5% | (many diffs) |
4 | human | 3812 | KIR3DL2 | killer cell immunoglobulin ... | NM_001242867.2 | 87.1% | 79.7% | (many diffs) |
5 | human | 3813 | KIR3DS1 | killer cell immunoglobulin ... | NM_001083539.2 | 84.8% | 79.7% | (many diffs) |
6 | human | 112268355 | LOC112268355 | killer cell immunoglobulin-... | NM_001368254.1 | 84.8% | 79.7% | (many diffs) |
7 | human | 3812 | KIR3DL2 | killer cell immunoglobulin ... | XM_011526940.3 | 83.7% | 76.9% | (many diffs) |
8 | human | 115653 | KIR3DL3 | killer cell immunoglobulin ... | NM_153443.4 | 80.3% | 70% | (many diffs) |
9 | human | 3803 | KIR2DL2 | killer cell immunoglobulin ... | NM_014219.2 | 72.7% | 67.3% | (many diffs) |
10 | human | 3802 | KIR2DL1 | killer cell immunoglobulin ... | NM_014218.3 | 72.1% | 66.2% | (many diffs) |
11 | human | 112267881 | LOC112267881 | killer cell immunoglobulin-... | NM_001368251.1 | 71.9% | 66.2% | (many diffs) |
12 | human | 3804 | KIR2DL3 | killer cell immunoglobulin ... | NM_015868.3 | 71.1% | 65% | (many diffs) |
13 | human | 3812 | KIR3DL2 | killer cell immunoglobulin ... | XM_017026784.2 | 70.9% | 64.7% | (many diffs) |
14 | human | 3811 | KIR3DL1 | killer cell immunoglobulin ... | XM_017030274.1 | 69.2% | 51.6% | (many diffs) |
15 | human | 100132285 | KIR2DS2 | killer cell immunoglobulin ... | NM_001291695.1 | 66.1% | 60.4% | (many diffs) |
16 | human | 3813 | KIR3DS1 | killer cell immunoglobulin ... | NM_001282170.1 | 63.4% | 58.6% | (many diffs) |
17 | human | 57292 | KIR2DL5A | killer cell immunoglobulin ... | NM_020535.3 | 63.3% | 55.2% | (many diffs) |
18 | human | 100132285 | KIR2DS2 | killer cell immunoglobulin ... | NM_012312.4 | 63% | 57.6% | (many diffs) |
19 | human | 100132285 | KIR2DS2 | killer cell immunoglobulin ... | XM_017030275.2 | 63% | 57.6% | (many diffs) |
20 | human | 553128 | KIR2DL5B | killer cell immunoglobulin ... | NM_001018081.1 | 62.8% | 54.1% | (many diffs) |
21 | human | 3805 | KIR2DL4 | killer cell immunoglobulin ... | NM_002255.6 | 62.1% | 52.5% | (many diffs) |
22 | human | 112268354 | LOC112268354 | killer cell immunoglobulin-... | NM_001368253.1 | 62.1% | 52.2% | (many diffs) |
23 | human | 3806 | KIR2DS1 | killer cell immunoglobulin ... | NM_014512.1 | 62% | 56% | (many diffs) |
24 | human | 3806 | KIR2DS1 | killer cell immunoglobulin ... | XM_011547998.2 | 62% | 56% | (many diffs) |
25 | human | 3809 | KIR2DS4 | killer cell immunoglobulin ... | NM_012314.6 | 61.8% | 56% | (many diffs) |
26 | human | 3810 | KIR2DS5 | killer cell immunoglobulin ... | NM_014513.2 | 61.7% | 55.6% | (many diffs) |
27 | human | 102725023 | LOC102725023 | killer cell immunoglobulin-... | NM_001360171.1 | 61.4% | 54.5% | (many diffs) |
28 | human | 3808 | KIR2DS3 | killer cell immunoglobulin ... | NM_012313.1 | 61.3% | 54.2% | (many diffs) |
29 | human | 3802 | KIR2DL1 | killer cell immunoglobulin ... | XM_017026782.1 | 61.1% | 56.7% | (many diffs) |
30 | human | 100132285 | KIR2DS2 | killer cell immunoglobulin ... | NM_001291701.1 | 59.5% | 54.2% | (many diffs) |
31 | human | 3813 | KIR3DS1 | killer cell immunoglobulin ... | NM_001282171.1 | 58.8% | 53.8% | (many diffs) |
32 | human | 3805 | KIR2DL4 | killer cell immunoglobulin ... | NM_001080770.2 | 56% | 47.5% | (many diffs) |
33 | human | 3806 | KIR2DS1 | killer cell immunoglobulin ... | XM_024452542.1 | 53.7% | 45.7% | (many diffs) |
34 | human | 3805 | KIR2DL4 | killer cell immunoglobulin ... | NM_001080772.2 | 52.3% | 44.1% | (many diffs) |
35 | human | 3802 | KIR2DL1 | killer cell immunoglobulin ... | XM_017026783.1 | 51.2% | 44.1% | (many diffs) |
36 | human | 3806 | KIR2DS1 | killer cell immunoglobulin ... | XM_024452543.1 | 50.9% | 46.6% | (many diffs) |
37 | human | 3806 | KIR2DS1 | killer cell immunoglobulin ... | XM_024452544.1 | 50.9% | 46.6% | (many diffs) |
38 | human | 3806 | KIR2DS1 | killer cell immunoglobulin ... | XM_024452545.1 | 50.9% | 46.6% | (many diffs) |
39 | human | 3809 | KIR2DS4 | killer cell immunoglobulin ... | NM_001281971.2 | 48.2% | 29.8% | (many diffs) |
40 | human | 3806 | KIR2DS1 | killer cell immunoglobulin ... | XM_017030286.1 | 46.9% | 41.4% | (many diffs) |
41 | human | 3802 | KIR2DL1 | killer cell immunoglobulin ... | XM_011526939.2 | 46.8% | 40.9% | (many diffs) |
42 | human | 3809 | KIR2DS4 | killer cell immunoglobulin ... | NM_001281972.2 | 44.7% | 30.5% | (many diffs) |
43 | human | 100132285 | KIR2DS2 | killer cell immunoglobulin ... | NM_001291696.1 | 41.1% | 36.4% | (many diffs) |
44 | human | 107987438 | LOC107987438 | uncharacterized LOC107987438 | XR_001756645.1 | 21.5% | (many diffs) | |
45 | human | 100132285 | KIR2DS2 | killer cell immunoglobulin ... | NM_001291700.1 | 20.7% | 15.9% | (many diffs) |
Sequence Information
Note: uppercase bases indicate empirically verified sequence.
- ORF start:
- 66
- ORF end:
- 1398
- ORF length:
- 1332
- Sequence:
-
1 gttcgttgca acaaattgat gagcaatgct tttttataat gccaaCTTTG TACAAAAAAG 61 TTGGCATGTC GCTCATGGTC GTCAGCATGG CGTGTGTTGG GTTGTTCTTG GTCCAGAGGG 121 CCGGTCCACA CATGGGTGGT CAGGACAAGC CCTTCCTGTC TGCCTGGCCC AGCGCTGTGG 181 TGCCTCGCGG AGGACACGTG ACTCTTCGGT GTCACTATCG TCATAGGTTT AACAATTTCA 241 TGCTATACAA AGAAGACAGA ATCCACGTTC CCATCTTCCA TGGCAGAATA TTCCAGGAGG 301 GCTTCAACAT GAGCCCTGTG ACCACAGCAC ATGCAGGGAA CTACACATGT CGGGGTTCAC 361 ACCCACACTC CCCCACTGGG TGGTCGGCAC CCAGCAACCC CATGGTGATC ATGGTCACAG 421 GAAACCACAG AAAACCTTCC CTCCTGGCCC ACCCAGGTCC CCTGGTGAAA TCAGGAGAGA 481 GAGTCATCCT GCAATGTTGG TCAGATATCA TGTTTGAGCA CTTCTTTCTG CACAAAGAGG 541 GGATCTCTAA GGACCCCTCA CGCCTCGTTG GACAGATCCA TGATGGGGTC TCCAAGGCCA 601 ATTTCTCCAT CGGTCCCATG ATGCTTGCCC TTGCAGGGAC CTACAGATGC TACGGTTCTG 661 TTACTCACAC CCCCTATCAG TTGTCAGCTC CCAGTGATCC CCTGGACATC GTGGTCACAG 721 GTCCATATGA GAAACCTTCT CTCTCAGCCC AGCCGGGCCC CAAGGTTCAG GCAGGAGAGA 781 GCGTGACCTT GTCCTGTAGC TCCCGGAGCT CCTATGACAT GTACCATCTA TCCAGGGAGG 841 GGGGAGCCCA TGAACGTAGG CTCCCTGCAG TGCGCAAGGT CAACAGAACA TTCCAGGCAG 901 ATTTCCCTCT GGGCCCTGCC ACCCACGGAG GGACCTACAG ATGCTTCGGC TCTTTCCGTC 961 ACTCTCCCTA CGAGTGGTCA GACCCGAGTG ACCCACTGCT TGTTTCTGTC ACAGGAAACC 1021 CTTCAAGTAG TTGGCCTTCA CCCACAGAAC CAAGCTCCAA ATCTGGTAAC CCCAGACACC 1081 TGCACATTCT GATTGGGACC TCAGTGGTCA TCATCCTCTT CATCCTCCTC CTCTTCTTTC 1141 TCCTTCATCT CTGGTGCTCC AACAAAAAAA ATGCTGCTGT AATGGACCAA GAGCCTGCAG 1201 GGAACAGAAC AGCCAACAGC GAGGACTCTG ATGAACAAGA CCCTGAGGAG GTGACATACG 1261 CACAGTTGGA TCACTGCGTT TTCACACAGA GAAAAATCAC TCGCCCTTCT CAGAGGCCCA 1321 AGACACCCCC TACAGATACC ATCTTGTACA CGGAACTTCC AAATGCTAAG CCCAGATCCA 1381 AAGTTGTCTC CTGCCCATGC CCAACTTTCT TGTACAAAGT tggcattata agaaagcatt 1441 gcttatcaat ttgttgcaac gaac